论文部分内容阅读
目的研究探讨依那普利和倍他乐克联合治疗慢性心力衰竭的临床效果。方法将我院2014年2月至2015年2月收治的慢性心力衰竭患者90例,按统计学原理分为数量均为45例的对照组和观察组。对照组患者在基础性药物治疗的同时给予倍他乐克进行治疗,观察组患者在对照组患者治疗的基础上联合使用依那普利进行治疗,比较两组患者的临床治疗效果。结果治疗结果表明,观察组患者治疗有效率为95.6%,对照组患者治疗有效率为71.1%,数据符合统计学差异(P<0.05);与此同时,观察组患者左室收缩末期内径(LVESV)、舒张晚期和早期流速峰值比(A/E)、左室射血分数(LVEF)等指标改善情况明显优于对照组患者。结论针对慢性心力衰竭患者,依那普利和倍他乐克联合治疗改善患者心功能状况具有明显的效果,值得在临床上推广应用。
Objective To investigate the clinical efficacy of enalapril and metoprolol in the treatment of chronic heart failure. Methods 90 patients with chronic heart failure admitted to our hospital from February 2014 to February 2015 were divided into control group and observation group according to the principle of statistics. Patients in the control group were treated with metoprolol at the same time as the basic drug treatment. Patients in the observation group were treated with enalapril on the basis of the treatment of the control group, and the clinical effects of the two groups were compared. Results The treatment results showed that the effective rate of treatment was 95.6% in observation group and 71.1% in control group (P <0.05). Meanwhile, the mean left ventricular end-systolic diameter (LVESV ), Late diastolic and early peak flow velocity (A / E), left ventricular ejection fraction (LVEF) and other indicators improved significantly better than the control group. Conclusions The combination of enalapril and metoprolol in patients with chronic heart failure has obvious effect on improving cardiac function in patients and is worth popularizing in clinic.